Global Health Limited (NSE:MEDANTA)
India
· Delayed Price · Currency is INR | Market Cap | 305.83B |
| Revenue (ttm) | 41.82B |
| Net Income (ttm) | 5.14B |
| Shares Out | 268.85M |
| EPS (ttm) | 19.10 |
| PE Ratio | 59.55 |
| Forward PE | 46.37 |
| Dividend | 0.50 (0.04%) |
| Ex-Dividend Date | n/a |
| Volume | 131,683 |
| Average Volume | 186,259 |
| Open | 1,167.10 |
| Previous Close | 1,167.80 |
| Day's Range | 1,132.85 - 1,179.00 |
| 52-Week Range | 956.00 - 1,456.50 |
| Beta | -0.02 |
| RSI | 65.47 |
| Earnings Date | May 15, 2026 |
About Global Health
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and d... [Read more]
Financial Performance
In fiscal year 2025, Global Health's revenue was 36.92 billion, an increase of 12.74% compared to the previous year's 32.75 billion. Earnings were 4.81 billion, an increase of 0.68%.
Financial StatementsNews
Medanta to invest Rs 550 crore in new 400-bed hospital in Varanasi
Global Health Limited, operating under the brand Medanta, has announced plans to establish a 400-bed multi-specialty hospital in Varanasi, Uttar Pradesh. The decision was made during a board meeting h...
Global Health Transcript: Q3 25/26
Q3 FY26 delivered 19% revenue growth and strong operational metrics, with Noida hospital ramping up as planned and mature/developing hospitals showing robust margins. ARPOB growth is expected to moderate, and CapEx will be lower next year as major investments are complete.
Global Health Q3 Results: Net profit falls 33.6% YoY to Rs 95 crore, revenue up 18.8% YoY
Global Health Limited, the company operating the Medanta hospital chain, reported a mixed set of Q3 results, with strong revenue...
Global Health Ltd (BOM:543654) Q2 2026 Earnings Call Highlights: Strong Financial Growth Amid ...
Global Health Ltd (BOM:543654) Q2 2026 Earnings Call Highlights: Strong Financial Growth Amid Expansion Challenges
Q2 2026 Global Health Ltd Earnings Call Transcript
Q2 2026 Global Health Ltd Earnings Call Transcript
Global Health Transcript: Q2 25/26
Q2 FY 2026 saw 15% YoY revenue growth, 21% PAT growth, and strong cash flows, driven by robust performance in both mature and developing hospitals. Noida Hospital commenced operations, and major expansion projects in Guwahati and Mumbai are underway. Talent retention remains strong, with industry-wide RPOP growth moderating.
Global Health Transcript: Q1 25/26
Q1 FY 2026 saw record income and EBITDA, with 19% revenue and 50% PAT growth year-on-year, driven by higher patient volumes and operational efficiency. Expansion continues with new hospitals in Ranchi and Noida, and a strong cash position supports future growth and acquisitions.
Global Health share jumps over 4% on strong Q1 earnings; profit rises nearly 50% YoY
Shares of Global Health Ltd, which operates under the Medanta brand, rose 3.72% to ₹1,376.40 in early trade on Thursday after the company posted robust earnings for the June quarter. In Q1FY26 (consol...
Medanta opens new 110-bed hospital in Ranchi, expands capacity
Global Health Limited, which operates hospitals under the Medanta brand, announced the commencement of operations at its newly constructed hospital in Ranchi today. As per the company’s filing with BS...
Global Health Transcript: Q4 24/25
Strong year-over-year growth in revenue, EBITDA, and patient volumes, with robust expansion plans including new hospitals in Mumbai, Pitampura, and Guwahati. Margins remain healthy, and the company declared its first-ever dividend, while maintaining a strong cash position and focusing on quality and capacity expansion.
Global Health shares rise over 2% as Medanta evaluates land offer for Assam hospital
Shares of Global Health Ltd, the operator of Medanta hospitals, jumped 2.35% to ₹1,224.05 in Monday’s trade after the company disclosed that it has received a formal offer from the Assam Electricity G...
Medanta receives offer from Assam govt to set up super speciality hospital in Guwahati
Global Health Limited, which operates under the brand name Medanta, has announced that it has received a formal offer from Assam Electricity Grid Corporation Limited (AEGCL), a government entity, for ...
Global Health Transcript: Q3 24/25
Q3 FY25 delivered double-digit revenue and profit growth, driven by higher patient volumes and strong performance in both mature and developing hospitals. Major expansion projects are on track, with significant bed additions and new facilities planned, while the company maintains a robust cash position and favorable cost ratios.
Global Health shares surge over 4% as EBITDA jumps 11% YoY in Q3
Global Health Ltd. saw its shares jump more than 4% after reporting robust Q3 earnings, reflecting steady growth in revenue and profitability. As of 9:31 AM, the shares were trading 4.70% higher at Rs...
Jefferies maintains Hold call on Medanta, target of Rs 1,170
Jefferies has maintained a 'Hold' rating on Global Health Limited (Medanta), with a target price of ₹1,170.
Global Health (Medanta) shares rise over 2% as Medanta announces new 750-bed hospital in New Delhi
As of 9:55 am, Global Health Limited (Medanta) shares were trading 1.96% higher at ₹1,095.15 on the NSE, following the announcement of a new 750-bed super-speciality hospital in New Delhi. This expans...
Medanta to operate 750-bed super speciality hospital in Delhi, commits ₹600 crore capex
Medanta, a prominent healthcare provider under Global Health Limited, has announced a new venture to operate and manage a 750-bed super speciality hospital in New Delhi. This expansion marks another s...
Global Health (Medanta) shares surge over 5% in morning trade
Global Health Limited, operating under the brand name Medanta, is witnessing a significant uptick in its stock price during early trading hours today. Key highlights: Current Trading: Stock Price: ₹1,...